Captrust Financial Advisors Neuronetics, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$2.09 - $3.71 $411 - $730	-197 Reduced 36.21%	347 $1,000
Q1 2022 May 16, 2022	BUY	$2.84 - $4.52 $559 - $890	197 Added 56.77%	544 $2,000
Q2 2021 Aug 16, 2021	SELL	$10.15 - $17.25 $60 - $103	-6 Reduced 1.7%	347 $6,000
Q1 2021 May 17, 2021	BUY	$10.6 - $21.27 $3,741 - $7,508	353 New	353 $4,000

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $82.1M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.